LeaderPortfolio
Samuelsson
Roger Samuelsson
Rank #1009
SWEDENHealthcareDrug delivery devices

Roger Samuelsson

Net Worth
$4.141B
0% (24h)
Roger Samuelsson is a Swedish entrepreneur and the owner of 68% of SHL Medical, the world's largest maker of autoinjectors. His wealth is primarily derived from his stake in SHL Medical, a company he co-founded in 1989. Samuelsson's career began with importing goods from Taiwan, later transitioning to medical device manufacturing. His achievements include pioneering autoinjectors, which have become essential for drug delivery. As of March 2026, his net worth is estimated at $4.1 billion, marking him as a self-made billionaire. He is also known for owning the megayacht Octopus and has been involved in car racing.

How to read Roger Samuelsson's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Roger Samuelsson, we anchor the narrative to Drug delivery devices and Drug delivery devices, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $4.141B alongside global rank #1009, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (SWEDEN) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life and Entrepreneurial Beginnings

Roger Ivar Samuelsson, born on December 10, 1963, in Svalöv, Sweden, began his entrepreneurial journey at a young age. As a sports enthusiast, he observed the production of sporting goods in Asia, which sparked his interest in importing. He started by importing boxing gloves and other items from Taiwan, laying the foundation for his future business ventures. After studying engineering, Samuelsson moved to Taiwan to further his business interests.

Rise to Success

In 1989, Samuelsson co-founded Scandinavian Health Systems (SHL), initially operating from his apartment. The company transitioned from an import agency to a manufacturer, focusing on medical devices, particularly injectors and systems for individual drug distribution. SHL Medical grew significantly under Samuelsson's leadership, employing around 3,000 people by 2016. The company has factories in Taiwan and China, with development divisions in Taiwan, Sweden, and the USA. The company's success is linked to the rising demand for autoinjectors, used for administering various medications, including those for weight loss and other chronic conditions. SHL Medical's clients include major pharmaceutical companies like Novo Nordisk, Amgen, and Pfizer.

Key Business Strategies

Samuelsson's approach to business is characterized by careful observation, attentive listening, thorough thinking, and decisive execution. SHL Medical's success is built on a foundation of innovation and strategic partnerships within the healthcare industry. The company has consistently upgraded its manufacturing and commercial capabilities. His company focuses on the development and manufacture of advanced drug delivery devices, such as autoinjectors, pen injectors, and innovative specialty delivery systems.

Philanthropy

While specific details of Roger Samuelsson's philanthropy are not readily available in the search results, his involvement and ownership of the Race4Health team, which combines motorsports with charitable initiatives, suggests an interest in using his resources for positive global change.

Career Timeline

2024

Billionaire Status

Achieved billionaire status due to the success of SHL Medical.

2021

Purchased the Octopus Yacht

Acquired the megayacht Octopus, previously owned by Paul Allen.

1989

Co-founded SHL Medical

Established SHL Medical, which became a leading manufacturer of autoinjectors.

Key Business Ventures & Holdings

CompanyStakeValue
SHL Medical68.00%

Net Worth History

In-Depth Analysis

Early Life and Entrepreneurial Beginnings

Roger Ivar Samuelsson, born on December 10, 1963, in Svalöv, Sweden, began his entrepreneurial journey at a young age. As a sports enthusiast, he observed the production of sporting goods in Asia, which sparked his interest in importing. He started by importing boxing gloves and other items from Taiwan, laying the foundation for his future business ventures. After studying engineering, Samuelsson moved to Taiwan to further his business interests.

Rise to Success

In 1989, Samuelsson co-founded Scandinavian Health Systems (SHL), initially operating from his apartment. The company transitioned from an import agency to a manufacturer, focusing on medical devices, particularly injectors and systems for individual drug distribution. SHL Medical grew significantly under Samuelsson's leadership, employing around 3,000 people by 2016. The company has factories in Taiwan and China, with development divisions in Taiwan, Sweden, and the USA. The company's success is linked to the rising demand for autoinjectors, used for administering various medications, including those for weight loss and other chronic conditions. SHL Medical's clients include major pharmaceutical companies like Novo Nordisk, Amgen, and Pfizer.

Key Business Strategies

Samuelsson's approach to business is characterized by careful observation, attentive listening, thorough thinking, and decisive execution. SHL Medical's success is built on a foundation of innovation and strategic partnerships within the healthcare industry. The company has consistently upgraded its manufacturing and commercial capabilities. His company focuses on the development and manufacture of advanced drug delivery devices, such as autoinjectors, pen injectors, and innovative specialty delivery systems.

Philanthropy

While specific details of Roger Samuelsson's philanthropy are not readily available in the search results, his involvement and ownership of the Race4Health team, which combines motorsports with charitable initiatives, suggests an interest in using his resources for positive global change.

Data Sources & Methodology

Figures for Roger Samuelsson are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.